Log in or Sign up for Free to view tailored content for your specialty!
Geriatric Medicine News
USPSTF: Insufficient evidence to make recommendations on glaucoma, impaired vision
The U.S. Preventive Services Task Force has issued draft recommendations that state there is not enough evidence to assess the balance of benefits and harms of screening some adults for primary open-angle glaucoma and impaired visual acuity.
FDA proposes rule to make hearing aids available over the counter
The FDA has proposed a rule that would allow some hearing aids to become available over the counter, and thus, make them potentially more affordable and accessible.
Log in or Sign up for Free to view tailored content for your specialty!
Adjunctive perampanel effective in older patients with focal-onset seizures
Long-term adjunctive perampanel treatment was efficacious and generally well tolerated among older patients with focal-onset seizures, according to findings presented at the annual meeting of the American Neurological Association.
Telehealth provides short-term benefits, but PCPs express concern for long-term damage
Nearly two-thirds of clinicians reported relying on telehealth during the COVID-19 pandemic to maintain patients’ access to care, according to survey findings from the Larry A. Green Center and the Primary Care Collaborative.
Vascular interventions may not reduce dementia incidence
Interventions that targeted vascular risk factors in a real-world setting did not appear to reduce dementia incidence in old age, according to study results in a research letter published in JAMA Neurology.
Adults with autism more than two times likely to receive dementia diagnosis
Adults with autism spectrum disorder were about 2.6 times more likely to be diagnosed with early-onset dementia than adults in the general population, according to a case control study published in Autism Research.
Gantenerumab receives breakthrough therapy designation as Alzheimer’s treatment
The FDA has granted breakthrough therapy designation to gantenerumab, an anti-amyloid beta antibody developed for subcutaneous administration, as an Alzheimer’s disease treatment.
Methylphenidate may reduce apathy in AD
Methylphenidate safely and effectively treated apathy in Alzheimer’s disease, according to results of a randomized placebo-controlled clinical trial published in JAMA Neurology.
Q&A: HIV, sexual activity need to be part of conversations with older patients, experts say
A case report of an 83-year-old man in Spain who was newly diagnosed with HIV highlights the importance of screening older adults, experts said.
Q&A: Addressing alcohol intake with older patients
Primary care physicians often face challenges discussing alcohol use with older patients, according to a study published in the British Journal of General Practice.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read